Connect with us

Health

Researchers examine potential SARS-CoV-2 antivirals using a drug repurposing library – News-Medical.Net

A new study deals with the screening of the Drug Repurposing Hub (DRH) library for identifying small compounds which are capable of inhibiting SARS-CoV-2 using…

Published

on

Article feature image

In December 2019, the emergence of a novel coronavirus in Wuhan, China, later identified as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was reported. Owing to the high global transmission of the virus, on the 11th of March 2020, the World Health Organization (WHO) announced coronavirus disease 2019 (COVID-19) to be pandemic.
Scientists have characterized SARS-CoV-2 and reported that it is a positive-sense, single-stranded RNA virus with a genome of approximately 29 kb, and it belongs…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending